OTCQB:FMCC - OTCQB:KBLB - OTCQB:KSHB - OTCQB:PHOT - OTCQB:TBPMF - OTCQX:ADRNY - OTCQX:LIHTF - PINK:PURA - 24/7 Market News

Venture Breakfast Bits, by 24/7 Market News

2018-11-20T09:50:42+00:00 Nov. 20, 2018 9:48AM EST|

Venture Market News for November 20, 2018

  • Kraig Biocraft Laboratories Signs Pivotal Agreement to Import and Rear Silkworms in Vietnam

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that it signed a key memorandum of understanding with the Institute of Biotechnology – Vietnam Academy of Science and Technology (“IoB-VAST”) and the Vietnam Sericulture Research Centre (“VSRC”) to import and rear its transgenic silkworms in Vietnam. This pivotal agreement provides a location, skilled workers, security, and necessary oversight, for the Company to import and begin testing its first batch of recombinant spider silk silkworm eggs in Vietnam

Full press release

  • KushCo Holdings Appoints Christopher Tedford as Chief Financial Officer

GARDEN GROVE, Calif., Nov. 20, 2018 (GLOBE NEWSWIRE) -- KushCo Holdings, Inc. (OTCQB: KSHB) (“KushCo” or the “Company”), the parent company of innovative industry leaders such as Kush Supply Co., Kush Energy, The Hybrid Creative, and Koleto Packaging Solutions, which provide a range of services and products for a variety of industries including the regulated cannabis and CBD industries, today announced it has appointed Christopher Tedford as the Company’s new Chief Financial Officer (“CFO”), effective November 26, 2018. Jim McCormick, the Company’s current CFO and Chief Operating Officer (“COO”) will transition exclusively into the COO position where he will focus on scaling the Company’s operational capacity to support its growth objectives.

Full press release

  • Freddie Mac Issues 2019 Debt Funding Calendar

MCLEAN, Va., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Freddie Mac (OTCQB: FMCC) today issued its 2019 funding calendar, which provides optional announcement dates for Reference Notes® securities and announcement and auction dates for Reference Bills® securities.  The 2019 funding calendar is available on the company’s website at www.freddiemac.com/debt.

Full press release

  • GrowLife, Inc. Launches Affiliate Program for Its Expanding E-Commerce Platform Designed to Engage Thought Leaders and Build Revenue

GrowLife, Inc. (OTCQB: PHOT) (“GrowLife” or the “Company”), one of the nation’s most recognized indoor cultivation product and service providers, today announced that it has launched an affiliate sales program which allows those who join as members to earn commission on all referrals they make to the Company that make a purchase through both company e-commerce platforms, ShopGrowLife.com in the U.S. and GrowLifeHydro.ca in Canada. The program is designed to continue to build high-margin sales revenue through the company’s e-logistics network.

Full press release

  • Ahold Delhaize share buyback update

Zaandam, the Netherlands, November 20, 2018 - Ahold Delhaize has repurchased 300,000 of Ahold Delhaize common shares in the period from November 12, 2018 up to and including November 16, 2018. The shares were repurchased at an average price of €22.81 per share for a total consideration of €6.8 million. These repurchases were made as part of the €2 billion share buyback program announced on November 8, 2017.

Full press release

  • Analyst Anticipates Puration Inc Sales to Reach $3 Million in 2019 With Hemp-based CBD Market Growing to $1.9 Billion

DALLAS, November 20, 2018 /PRNewswire/ --Puration, Inc.(USOTC: PURA) today announced that Goldman Small Cap Research issued a research update on the Company. The report includes a 'speculative-buy' rating with a target price-per-share of $0.25. The report previews upcoming milestones and provides an analysis of Puration's recent financial results and new initiatives. To view the update report, along with disclosures and disclaimers, visit http://www.GoldmanResearch.com or view the report on the company's website at https://www.purationinc.com/goldman-3q2018-update.

Full press release

  • Tetra Bio-Pharma Enters into Binding Proposal with Quantum Pharma Inc.

ORLEANS, Ontario, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (“Tetra” or “TBP”), (TSX VENTURE: TBP) (OTCQB: TBPMF), and Quantum Pharma Inc. (“Quantum”) today announced the signing of a binding proposal (the "Proposal") for exclusive access to a Health Canada licensed facility (i.e., Drug Establishment License; DEL) that enables the company to produce cannabis and cannabinoid drug products for Tetra’s and Panag Pharma’s development activities including the ocular drug formulations.   Quantum Pharma owned by Dr. Peter Ford was the GMP manufacturing division of Ford’s Family Pharmacy and Wellness Centre.  Their formulation expertise will enable Tetra to develop innovative products for future clinical trials.

Full press release

  • Liht Cannabis Corp. receives state approval to commence operations in its second building in North Las Vegas, Nevada

KELOWNA, BC, Nov. 20, 2018 /PRNewswire/ - Liht Cannabis Corp. (CSE: LIHT) (OTCQX: LIHTF) (FSE: 2M0) ("Liht") or (the "Company") is pleased to announce that further to its November 7, 2018, news release, the Company has received final approval from the State of Nevada to commence operations in the second 5,000 sq. ft. building in North Las Vegas, immediately.

Full press release

Connect with 24/7 Market News on social media

https://twitter.com/247MarketNewsHQ

https://www.facebook.com/247MarketNewsHQ/

About 24/7 Market News

As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information.  24/7 MN provides comprehensive corporate communications resources and tools to engage the investment community.

DISCLAIMER:

24/7 Market News (24/7MN) is a third party publisher and news dissemination service provider that produces regular sponsored and non-sponsored reports, articles, stock market blogs, and newsletters covering equities listed on the NYSE, NASDAQ and micro-cap exchanges. 24/7MN holds no investment licenses and is NOT a financial advisory firm, investment adviser, analyst, or broker-dealer and does not undertake any activities that would require such registration. 24/7MN's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.

The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. 24/7MN owns KBLB shares that it can sell at any time. All material included herein is republished content and based on publicly available information which is believed to be reliable. 24/7MN makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice.   24/7MN and/or its affiliates are not responsible for any gains or losses that result from the opinions expressed and are not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.

For further information on 24/7 Market News, please go to www.247marketnews.com 

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan," or "planned," "will," or "should," "expected," "anticipates," "draft," "eventually," or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and 24/7MN undertakes no obligation to update such statements

CONTACT:

24/7 Market News

Editor@247marketnews.comTop of Form

Send this to a friend

Hi, this may be interesting you: Kraig Biocraft Laboratories’ New R&D Facility Extends Its Competitive Advantages and Prepares for Large Scale Production! This is the link: https://www.247marketnews.com/kraig-biocraft-laboratories-new-rd-facility-extends-its-competitive-advantages-and-prepares-for-large-scale-production/